All In MedTech

Device Trial Radar · NCT07949643

Operator-Assisted Oscilla Audiometry as a Basis for Hearing Aid Fitting (The Oscilla Validation Study)

Validation of Operator-Assisted Oscilla Audiometry as a Diagnostic Tool and Basis for Hearing Aid Fitting in Adults With Uncomplicated Hearing Loss: A Blinded Non-Inferiority Randomised Controlled Trial

Last checked: Nov 19, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingRandomized with 268 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

268

Planned (sponsor's estimate)

Start

Dec 1, 2026

Primary completion

Oct 31, 2027

Study completion Oct 31, 2027

Sponsor

Lead sponsor
Aalborg University HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 19, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Diagnostic
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to find out whether hearing tests performed with the Oscilla A60 audiometer, where the patient largely tests themselves with minimal staff assistance, are accurate enough to be used for diagnosing hearing loss and as the sole basis for fitting hearing aids. Adults referred for their first hearing aids at Aalborg University Hospital will have their hearing tested both with the Oscilla audiometer and by a trained audiology assistant at the same visit. Participants are then randomly assigned to receive hearing aids fitted based on either the Oscilla hearing test or the audiology assistant's hearing test. The main questions are: (1) Do the Oscilla results agree with the audiology assistant's results for both air-conduction and bone-conduction hearing thresholds? (2) Do participants fitted based on the Oscilla test report a hearing benefit that is not worse than that of participants fitted based on the standard test, two months after fitting?

Conditions

  • Hearing Loss, Sensorineural
  • Presbyacusis

Interventions

  • Paired audiometry (Oscilla A60 and manual audiometry)Diagnostic test

    At Visit 1, all participants undergo both operator-assisted Oscilla A60 audiometry (AudioConsole v4.6.0; AC and BC thresholds; operator places the BC headband only) in a quiet room (\<50 dB SPL) and manual pure-tone audiometry (AC and BC, ISO 8253-1) by a qualified audiology assistant in a sound-attenuating booth, in randomised order.

  • Oscilla-based hearing aid fittingDevice

    Bilateral BTE/RIC hearing aid fitting to NAL-NL2 targets using the Oscilla A60 audiogram as the sole audiometric basis, verified with auto-REM (within ±5 dB of target). Other names: Oscilla A60 Diagnostic Audiometer.

  • Manual audiometry-based hearing aid fittingDevice

    Bilateral BTE/RIC hearing aid fitting to NAL-NL2 targets using the audiology assistant audiogram, verified with auto-REM (within ±5 dB of target). Standard clinical practice.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Agreement between Oscilla A60 and manual audiometry for air-conduction thresholdsTime frame: Visit 1 (Week 0)
  2. Agreement between Oscilla A60 and manual audiometry for bone-conduction thresholdsTime frame: Visit 1 (Week 0)
  3. Change in SSQ12 total scoreTime frame: Baseline (Week 0) and 2 months after hearing aid fitting

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Department of Audiology, Aalborg University Hospital

    Aalborg, Denmark

  • Hearing Clinic, Aalborg University Hospital

    Hobro, Denmark

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.